a r t I C l e S Directed differentiation from pluripotent stem cells and lineage reprogramming of fibroblasts can both be used to derive a wide range of different neuronal subtypes 1, 2 . Although the known sequence of morphogen exposure and consequent molecular changes in the development of specific neurons can guide directed differentiation strategies, the selection of transcription factors for lineage reprogramming from fibroblasts remains essentially empirical. No single transcription factor has proven to be essential for driving cell fates in all of the neuronal reprogramming studies to date, despite the fact that specific factors such as Ascl1 or Ngn2 seem particularly potent in deriving a range of different neuronal subtypes 3 . Brn2, Ascl1 and Myt1l (or BAM) generate generic neurons on their own 4 and specific neuronal subtypes when combined with additional factors 5 . Moreover, the developmental stage at which a particular transcription factor acts in vivo may determine whether that factor facilitates or inhibits the patterning of reprogrammed neurons 4, 5 .
Nociceptors are the first-order neurons in the pain sensory transduction pathway and take the critical initial step in the detection of noxious stimuli (nociception) and the development of inflammatory and neuropathic pain 6, 7 . Nociceptor neurons employ a host of highly specific ionotropic receptors and ion channels, including TrpV1, TrpA1, TrpM8 and P2X3 receptors to transduce stimuli, and slow, tetrodotoxin (TTX)-resistant sodium channels (Na V 1.8 and Na V 1.9) that generate their characteristic broad action potentials 8 . Efforts to derive nociceptors using a small molecule-based directed differentiation strategy from human neural crest precursors have produced neurons that recreate some, but not all, of these characteristic receptors and channels 9 .
Mutations in nociceptor-specific membrane proteins underlie a wide range of pain diseases, including rare, but severe, channelopathies resulting from Na V 1.7 or TrpA1 mutations 10 , common small fiber neuropathies resulting from activating mutations in Na V 1.7 or Na V 1.8 (refs. 11,12) , as well as a variety of pain-predisposing polymorphisms 13, 14 ; however, the biological effects of these mutations on nociception have not been studied in human sensory neurons. Nociceptors normally activate only following intense, potentially damaging stimuli to provide a protective warning of imminent tissue injury. However, they also have the notable capacity to become sensitized after exposure to inflammatory mediators 15, 16 or by chemotherapeutic drugs 17 , resulting in a reduced activation threshold so that innocuous stimuli can generate a pain response. Pain hypersensitivity can have a physiologically useful role in minimizing further injury and in promoting healing once damage has occurred; however, such transient sensitization, when it persists, promotes the development of chronic pain.
Nociceptor neuron development occurs through dorsalization in the neural tube 18 , followed by neural crest induction and migration 19 , Reprogramming somatic cells from one cell fate to another can generate specific neurons suitable for disease modeling. To maximize the utility of patient-derived neurons, they must model not only disease-relevant cell classes, but also the diversity of neuronal subtypes found in vivo and the pathophysiological changes that underlie specific clinical diseases. We identified five transcription factors that reprogram mouse and human fibroblasts into noxious stimulus-detecting (nociceptor) neurons. These recapitulated the expression of quintessential nociceptor-specific functional receptors and channels found in adult mouse nociceptor neurons, as well as native subtype diversity. Moreover, the derived nociceptor neurons exhibited TrpV1 sensitization to the inflammatory mediator prostaglandin E2 and the chemotherapeutic drug oxaliplatin, modeling the inherent mechanisms underlying inflammatory pain hypersensitivity and painful chemotherapy-induced neuropathy. Using fibroblasts from patients with familial dysautonomia (hereditary sensory and autonomic neuropathy type III), we found that the technique was able to reveal previously unknown aspects of human disease phenotypes in vitro. a r t I C l e S and then nociceptor specification in the still-multipotent neural crest lineage 20 . The generation of nociceptor progenitors expressing the TrkA neurotrophin receptor (Ntrk1) and postnatal nociceptors expressing TrpV1 requires the basic helix-loop-helix transcription factor Ngn1 (Neurogenin1), which is normally present from approximately E9-13 in the embryonic mouse 21 . Although developing nociceptors express multiple Trk-family receptors, maturing nociceptors express only TrkA. Brn3a (POU4F1) promotes Runx1 expression, which, together with Isl1 (Islet 1) and Klf7, maintains TrkA expression in developing nociceptors [22] [23] [24] [25] . A subset of nociceptors that become the peptidergic subclass of nociceptors maintain TrkA expression and express calcitonin gene-related peptide (CGRP, CalcA) and substance P. For non-peptidergic nociceptors, most of which bind isolectin B4, the glial cell-derived neurotrophic factor (GDNF) receptor Ret replaces TrkA in a process dependent on Runx1, and the loss of Runx1 markedly reduces TrpV1 expression 23 .
We set out to produce nociceptor neurons through transcriptionmediated lineage conversion of fibroblasts. From an initial set of 12 factors, we found that expressing five factors was sufficient to generate functional mouse nociceptor neurons. In a direct comparison between the induced nociceptors and primary adult mouse nociceptors, we found that the induced neurons mimicked bona fide nociceptors with regard to the function of the specific individual receptors and channels, such as TrpA1, TrpM8, P2X3 and Na V 1.8, as well as with regard to the population diversity. The induced neurons also modeled inflammatory peripheral sensitization, a critical process that underlies transient pain hypersensitivity and contributes to the pathological transition to chronic pain, as well as sensitization following exposure to the chemotherapeutic drug oxaliplatin. Finally, we derived human nociceptor neurons from patients with familial dysautonomia (FD); these neurons revealed potentially disease-relevant phenotypes in vitro.
RESULTS

Selection and optimization of transcription factors
We first developed nociceptor reporter mice by taking advantage of an existing Trpv1-Cre driver 26 and loxP-flanked tdTomato mice to generate Trpv1-Cre +/− ::tdTomato +/− reporter mice, from which we obtained mouse embryonic fibroblasts (MEFs). Activation of the tdTomato reporter signaled the conversion of the MEFs to TrpV1-expressing cells ( Supplementary Fig. 1 ). We began with nine transcription factors that were selected to promote lineage conversion to nociceptors in combination with the three BAM factors (12 total; Table 1 ). These factors were chosen using a combination of previous studies, transcription factor expression profiles in FACS-sorted adult mouse nociceptors (Na V 1.8 positive) as compared with proprioceptors (parvalbumin positive) (Chiu, I.M., Barrett, L.B., Williams, E., Strochlic, D.E., Lee, S. et al., unpublished data) , an expression profile similarity to Na V 1.8 in the BioGPS database 27 , and postnatal dorsal root ganglion (DRG) expression in the Allen Brain Atlas 28 .
As expected, there was no baseline activation of the tdTomato reporter in MEFs (data not shown). Staining of MEFs for neuronal precursor markers using antibodies to Nestin, Sox1 and Ki67, as well as for neuron-specific class III β-tubulin (Tuj1), was negative in each case ( Supplementary Fig. 2) . After transducing the fibroblasts with a combination of all 12 individual retroviruses containing the selected transcription factors, we detected a small number of tdTomato-positive cells with a neuronal morphology after 2 weeks ( Supplementary Fig. 3a ). To identify those transcription factors that were either critical for or inhibitory to lineage reprogramming into TrpV1-expressing cells, we then sequentially eliminated each factor, one at a time. To our surprise, the omission of some transcription factors strongly supported by the literature as having a role in promoting TrpV1 expression, such as Runx1, did not eliminate TrpV1 reporter expression ( Supplementary Fig. 3b ). In fact, omission of Brn3a led to a marked increase in the number of tdTomato-positive cells (Supplementary Fig. 3c ). We identified from this iterative process three factors that were critical to the TrpV1 lineage reprogramming process in that their omission led to a near complete absence of tdTomato and neuronal class III β-tubulin (Tuj1)-positive cells bearing a neuronal morphology: Ascl1, Myt1l and Klf7 (Supplementary Fig. 3d-f ).
When we combined the three BAM factors with Isl2, Ngn1 and Klf7, we again observed only a small number of tdTomato-and Tuj1-positive cells ( Fig. 1a) . Because prior studies 5 and our initial drop out experiments detected specific factors that could inhibit the lineage reprogramming process, we performed single factor dropouts from these six factors and found that omission of Brn2 led to a marked increase in the number of tdTomato-positive neurons ( Fig. 1b) , giving a yield of approximately 14% of plated fibroblasts that were both tdTomato and Tuj1 positive (less than 0.1% were tdTomato positive and Tuj1 negative). Removal of any other factor from the six sharply reduced the number of tdTomato-positive neurons ( Fig. 1c-h ). Next, we evaluated Ngn1 alone and in combination with the BAM factors; however, the yield was much lower than with the optimized five factor combination ( Supplementary Fig. 4 ). Indeed, further removal of any of the five factors resulted in a marked decrease in tdTomato-and Tuj1-positive cells ( Supplementary Fig. 5 ).
Molecular characterization of induced mouse nociceptors
To determine whether tdTomato-positive reprogrammed neurons phenocopied bona fide nociceptors, we evaluated the expression of protein markers specific for nociceptor neurons. Nearly all tdTomatopositive neurons stained for the pan-neuronal marker Tuj1 and had a neuronal-like morphology with many long branching axons, and most Tuj1-positive neurons were also tdTomato positive ( Fig. 2a) . Staining with an antibody to TrpV1 confirmed the translation of the TrpV1 protein in the vast majority of tdTomato-positive neurons npg a r t I C l e S ( Fig. 2b) . In mouse DRG, most TrpV1-expressing neurons are C fibers that express the marker peripherin (Prph) 29 , whereas only a small percentage of A-δ fibers are also TrpV1 positive 26 . In the induced neurons, a majority of tdTomato-positive neurons expressed peripherin (66.9 ± 4.1%, n = 16 wells from 4 separate transductions; Fig. 2c ) and many expressed CGRP (22.3 ± 6.6%, n = 4 wells from 2 separate transductions; Fig. 2d ); however, a smaller number of cells stained for the intermediate filament NF200, a marker of myelinated A-δ nociceptors in this context ( Fig. 2e) . In contrast, the derived nociceptors did not stain for smooth muscle actin (SMA), a marker of muscle, despite reports of TrpV1 expression in muscle 30 ( Supplementary  Fig. 6a,b ). Furthermore, neurons derived from the three BAM factors did not express nociceptor markers, consistent with their high specificity ( Supplementary Fig. 6c-g) .
Because specific antibodies do not exist for many quintessential nociceptor proteins, we used quantitative RT-PCR to compare nociceptor marker mRNA levels in tdTomato-positive induced nociceptors and tdTomato-positive adult mouse nociceptors relative to levels in MEFs ( Fig. 2f) . For this analysis, we used patch pipettes to pick tdTomato-positive induced and primary mouse neurons, as well as MEFs, and plotted the levels of specific transcripts in induced and primary nociceptors relative to MEFs. The fibroblast marker S100a4 was expressed at a similar very low level in both the induced and primary nociceptors, consistent with a non-fibroblast identity of the induced nociceptors. Na V 1.7 (Scn9a), which is found in nociceptor and autonomic peripheral neurons, was present in both the induced and primary nociceptors, as was TrkA (Ntrk1), which is turned on in developing nociceptors and persists in the peptidergic subset of mature nociceptors, although the expression of Na V 1.7 and TrkA in the induced neurons was several fold less than that in the primary DRGs. Together, these immunohistochemistry and PCR data suggest that the induced neurons express a complement of bona fide nociceptor-specific markers.
Functional properties of induced mouse nociceptors
To investigate the functional properties of the induced nociceptors, we performed calcium imaging with a battery of agonists and evaluated the number of responders in the tdTomato-positive population with a stable baseline and response to KCl (which activates voltage-gated calcium channels through depolarization and serves as a measure of neuronal functional integrity; Fig. 3a ). We chose concentrations of agonists for TrpM8 (250 µM menthol), TrpA1 (100 µM mustard oil) and TrpV1 (1 µM capsaicin) that only activated their respective cognate receptors 31 . We found that 39% of the cells responded to capsaicin, 9% to mustard oil and 3% to menthol (n = 227 tdTomatopositive cells that responded to KCl; Fig. 3a,b ). There were occasional cells that responded to both mustard oil and capsaicin, a single cell that responded to menthol and mustard oil, but not capsaicin, and one cell that responded to all three agonists. We did not observe any tdTomato-positive cells that responded to menthol alone, but we did identify a small number of tdTomato-negative cells that responded to menthol, but not the other Trp agonists ( Supplementary Fig. 7a ).
In contrast, none of the 50 KCl-responding neurons derived from the BAM factors alone responded to capsaicin (data not shown). Using the same experimental procedure, we then asked how the frequencies of the different combinations of receptors in individual neurons compared between induced nociceptors and adult mouse nociceptors. Tomato Tuj1
Tomato Tuj1
Tomato Tuj1 npg a r t I C l e S In tdTomato-positive primary DRG neurons dissected and cultured from adult Trpv1 +/-::tdTomato +/mice, we found that 36% of the neurons responded to capsaicin, 2.5% to mustard oil and 2.5% to menthol (n = 249 tdTomato-positive cells that responded to KCl; Supplementary Fig. 7b,c) . Thus, the nociceptor lineage reprogramming not only yielded physiologically functional TrpV1, TrpA1 and TrpM8 proteins in the induced neurons, but the frequencies and combinations of the different receptors in the induced neurons closely mimicked those of adult mouse nociceptors.
Although calcium imaging provides detailed information about calcium entry through Trp channels, it does not evaluate whether activation of these channel evokes action potential firing in the neurons. By culturing the induced neurons on extracellular multielectrode arrays (MEAs), we found that both capsaicin and mustard oil application evoked robust action potential firing from the induced neurons (three of three arrays for capsaicin and three of three arrays for mustard oil; Fig. 3c ).
We next used whole-cell patch-clamp recordings to define the electrophysiological properties of the induced nociceptors and found that capsaicin (1 µM) elicited inward currents in 6 of 11 tdTomatopositive induced neurons, consistent with, but somewhat higher than, the calcium imaging results (Fig. 4a) . The P2X3 subtype of ionotropic purinergic receptors is expressed specifically in nociceptor neurons 32 . Application of the P2X3-specific agonist α,β-methylene-ATP (30 µM) elicited rapidly-adapting inward currents in 8 of 16 neurons ( Fig. 4b) that were blocked completely by A-397491, a specific P2X3 antagonist, in four of four neurons (data not shown) 33 .
Perhaps the most nociceptor-specific functional marker is the TTX-resistant Na V 1.8 sodium channel, which produces a portion of the current in the nociceptor action potential upstroke 34 . In voltage clamp, we found that depolarizing voltage steps elicited inward sodium currents both before and after the application of 300 nM TTX (14 of 15 recorded induced nociceptors had TTX-resistant sodium currents greater than 50 pA; Fig. 4c ). Consistent with our expression studies, the slow channel kinetics of the TTX-resistant currents are typical for Na V 1.8 as opposed to the fast Na V 1.5 cardiac sodium channel, which is present in developing embryonic nociceptors 35 . Furthermore, 5 of 14 neurons with TTX-resistant sodium currents also exhibited a persistent sodium component, which previous studies have found to be a result of Na V 1.9 ( Fig. 4c) 34, 36 . The ability to generate action potentials in the presence of TTX is a feature of nociceptors, but not of other DRG or central neurons. The induced neurons fired single TTX-resistant action potentials that overshot 0 mV in 7 of 12 neurons (Fig. 4d) . Na V 1.8 is responsible for the characteristic broad action potential shape of the nociceptor action potential 8 , which we found to be a property of the induced neurons (mean action potential width of 3.32 ± 0.33 ms, n = 13 cells); as expected, adult primary tdTomato-positive nociceptors fired broad action potentials, but large tdTomato-negative primary non-nociceptor DRG neurons did not ( Fig. 4e) . In addition to differences in action potential morphology, 37 . Induced nociceptors fired tonic action potential trains in response to depolarizing current steps in 12 of 13 cells, consistent with the tonic firing found in tdTomato-positive adult primary mouse nociceptors, and in contrast with the single action potentials elicited in non-nociceptor, large tdTomato-negative adult DRG neurons (Fig. 4f) .
Although hyperpolarization-activated cyclic nucleotide-sensitive (HCN) currents are not specific for nociceptor neurons, they have an important role within these cells in neuropathic and inflammatory pain 38 , and their presence may be important for disease modeling. We found that the induced nociceptors produced typical sag depolarizations in response to hyperpolarization (Fig. 4g ) in 11 of 17 tdTomato-positive induced neurons, consistent with ZD7288sensitive HCN currents recorded in voltage clamp (two of two neurons, data not shown).
A critical function of peptidergic neurons, most of which express TrpV1 (ref. 7) , is to release neuropeptides such as CGRP and substance P. To assess the fidelity of the induced nociceptors in this capacity, we measured CGRP levels in supernatant following a depolarizing stimulus and found that induced nociceptors, but not BAM-derived neurons, released CGRP after KCl stimulation (n = 4 separate dishes, Mann-Whitney U test, P = 0.03; Fig. 4h ). The concentrations of CGRP released by the induced neurons were comparable to those released by primary DRG neurons (Supplementary Fig. 8) , indicating that the induced neurons have synaptic vesicle release mechanisms in place.
Induced nociceptors model inflammatory sensitization
The transition from high-threshold baseline nociception to lowthreshold clinical pain hypersensitivity commonly involves peripheral sensitization of nociceptors. For the induced nociceptors to be valuable in vitro models of in vivo pathophysiology, they must replicate not only the specific functional channels and receptors of the cells, but also the process of sensitization that leads to pathological pain. Prostaglandin E2 (PGE2) activates the PKA pathway and sensitizes the TrpV1 receptor, reducing its threshold and decreasing desensitization 15, 16 . In the tdTomato-positive induced neurons, a low concentration (300 nM) of capsaicin rarely yielded a large response (mean change in fluorescence absorption ratio of 0.028 ± 3.0 × 10 −3 ; Fig. 5a,b) . However, after treatment with PGE2 (1 µM) for 2 min, a second identical capsaicin (300 nM) application yielded a mean response of 0.18 ± 6.0 × 10 −3 (n = 41 cells, paired t test, P = 1.5 × 10 −4 ). Plotting the magnitudes of the initial capsaicin and PGE2-sensitized capsaicin responses revealed that, although the majority of neurons exhibited small or undetectable initial responses to capsaicin, they produced robust signals after PGE2 sensitization (Fig. 5c ).
TrpV1 sensitization also may contribute to painful chemotherapyinduced neuropathy due to oxaliplatin 17 . Using MEA recording, we compared capsaicin responses in induced nociceptors treated with either 50 µM oxaliplatin or vehicle control, and found marked sensitization in the oxaliplatin-treated nociceptors (Fig. 5d,e ).
Induction of human nociceptors
To derive nociceptors from human fibroblasts, we initially included NEUROD1 in the nociceptor induction protocol, as this transcription factor was important in prior human lineage reprogramming studies 39 . However, we found that the reprogramming efficiency was greater without NeuroD1 (five factors) than with NeuroD1 (six factors) (20.7 ± 1.4 Tuj1-positive neurons per field for five factors, 9.7 ± 1.1 for six factors, n = 6 wells per group, t test, P = 1.0 × 10 −4 ; Supplementary Fig. 9 ). Furthermore, more neurons exhibited larger sodium currents without NeuroD1 (67% of patched five factor neurons had peak transient sodium currents greater than 500 pA versus 29% of six factor neurons), and five factor neurons were healthier (resting V m = −49.3 ± 2.2 mV, n = 33 five factor neurons; V m = −37.3 ± 3.2, n = 20 six factor neurons; Mann-Whitney U test, P = 0.001). npg a r t I C l e S Using healthy control (HC) subject fibroblasts, we found that the five factors yielded Tuj1-positive neurons at an efficiency of 5% of plated fibroblasts, and that 16% of the Tuj1-positive neurons also expressed peripherin (Fig. 6a,b) ; these efficiencies were somewhat lower than those of the mouse induced nociceptors. A small number of the Tuj1positive neurons were NF200 positive ( Fig. 6c) . We recorded from the neurons using whole-cell patch clamp. Although we did not have a reporter for a particular neuronal subtype, the induced human neurons fired broad action potentials (mean action potential width = 3.88 ± 0.41 ms, n = 17 neurons; Fig. 6d ), consistent with functional nociceptors. In 38 voltage-clamp recordings, we applied TTX to neurons with a large total sodium current (greater than 1 nA) and detected TTX-resistant sodium currents in ten of ten neurons (Fig. 6e) . As in both our mouse induced nociceptors and primary mouse and human nociceptors 34, 36 , the induced human neurons had different combinations of slow and persistent TTX-resistant sodium currents, consistent with Na V 1.8 and Na V 1.9 contributions, respectively (Fig. 6e) .
To evaluate the potential of the human neurons for disease modeling, we reprogrammed fibroblasts from three HCs and three unrelated, age-matched subjects with familial dysautonomia (FD, hereditary sensory and autonomic neuropathy type III, Riley-Day syndrome) resulting from a homozygous donor splice site mutation that results in deletion of intron 20 from the I-κ-β kinase complexassociated protein (IKBKAP) RNA 40 . We found that single FD-derived neurons picked using patch pipettes exclusively expressed the abnormally spliced transcript, something not previously identified, whereas the HC-derived neurons expressed only the normal transcript (Fig. 6f) . FD fibroblasts expressed a mixture of abnormally spliced and normal transcripts, consistent with prior studies 41, 42 , whereas HC fibroblasts expressed only the normal transcript ( Fig. 6f and  Supplementary Fig. 10) .
Although we detected peripherin-positive, Tuj1-positive neurons from all HC and FD subjects (Fig. 6g,h) , the number of neurons was decreased in FD subjects (16.5 ± 1.1 HC neurons per well, n = 60 wells; 14.1 ± 1.1 FD neurons per well, n = 60 wells; difference between HC neurons per well and FD neurons per well = 2.3 ± 1.5, n = 60 wells; random intercept mixed-effects model, P = 0.26; Fig. 6i ) and we observed a robust reduction in neurite outgrowth per cell (725 ± 24 µm per HC neuron, n = 60 wells; 433 ± 25 µm per FD neuron, n = 60 wells; difference between HC neuron outgrowth per cell per well and FD neuron outgrowth per cell per well = 291.3 ± 32.6 µm, n = 60 wells; random intercept mixed-effects model P = 0.012; Fig. 6j ), as well as in the number of branches per neuron (7.9 ± 0.3 branches per HC neuron, n = 60; 4.7 ± 0.3 branches per FD neuron, n = 60 wells; difference between HC braches per neuron per well and FD branches per neuron per well = 3.3 ± 0.4, n = 60 wells; random intercept mixed-effects model, P = 0.017; Fig. 6k ) compared with HC-derived neurons.
DISCUSSION
The subjective nature of pain as a human experience confounds its clinical study, raises questions about the relevance of animal models and complicates the development of effective treatments 43 . Furthermore, limited physiological studies of primary human nociceptors highlight differences between human and rodent nociceptors, including the function of individual channels and receptors as well as their distribution in different nociceptor subtypes 44 , thereby emphasizing the importance of investigating human nociception using human nociceptors. Modeling key mechanistic aspects of human pain processing with derived human cells may enable phenotypic screens for analgesics based on basal and sensitized neurons from chronic pain subjects. Such approaches would improve on current drug screens that employ heterologously expressed targets in (c) NF200-positive cell derived from HC fibroblasts. (d) Current recording of an action potential from a HC-derived neuron (17 of 33 induced neurons with peak Na current > 500 pA fired at least one action potential with peak greater than 0 mV). (e) Total (left) and TTX-resistant (middle) sodium currents from a single HC-derived neuron. Right, persistent TTXresistant sodium current recordings from a separate HC-derived neuron characteristic of Na V 1.9. (f) RT-PCR for IKBKAP and GAPDH from single human induced neurons (left) and single human fibroblasts (right) showed normal (black arrow) and abnormally spliced (red arrowhead) transcripts. Full-length gels are presented in Supplementary Figure 10 . a r t I C l e S non-neuronal cells and consequently do not reflect the native scaffolding and molecular signaling present in human neurons, the pathophysiological changes that drive clinical pain and genetic backgrounds that may increase pain susceptibility. We found that a small number of transcription factors can quite efficiently convert fibroblasts into neurons that express the key specific functional receptors found in bona fide adult nociceptors. Although TrpV1 is expressed in a tiny fraction of central neurons 30 , Na V 1.8 and TrpA1 are not expressed in the CNS. The collective expression of subsets of these markers defines specific subpopulations 7 , and, to a first approximation, our neurons recreated the combinatorial patterns that define the diversity of TrpV1-expressing nociceptive neuronal cohorts found in primary mouse nociceptors. Notably, we seemed not to have derived a single nociceptor type, but instead engineered multiple subtypes of cells with properties and frequencies similar to those found in vivo. Three possible explanations will need to be investigated in future studies. First, there may be an autonomous program driving the native lineage diversity that is replicated by our transcription factors. Second, non-cell autonomous communication among neurons could influence their identity. Third, different identities could reflect different relative levels of transcription factor expression.
Although the transcription factor combinations that facilitate induction of specific fates have typically incorporated factors known to have defined roles in the development of those neurons 1 , some of the factors that we used do not have any well-defined developmental role. We chose Isl2 because of its strong differential expression in FACS-sorted nociceptors compared with proprioceptors and an expression pattern similarity to Na V 1.8 (ref. 27 ), although nothing is known about its role in nociceptor development. Notably, the in situ expression of Isl2 appears much more nociceptor specific than that of Isl1 (refs. 27,28), for which a role in nociceptor development and TrpV1 expression has been documented 24 , although another report found broader RNA expression of Isl2 (ref. 45) . Our results also raise questions as to why specific transcription factors facilitate or inhibit the reprogramming both to neuronal and nociceptor lineages. In contrast with prior studies 4,5,39 , we found that Brn2 inhibited lineage reprogramming of mouse fibroblasts to neurons, and NeuroD1 decreased the efficiency and quality of human neurons. With regard to the nociceptor lineage, the roles of Brn3a and Klf7 in maintaining TrkA expression during embryonic development appear similar in the literature 22, 25 . However, we found that Brn3a markedly inhibits lineage reprogramming to nociceptors, whereas Klf7 promotes it. Runx1, which is active and critical in the later embryonic stages of nociceptor development, does not facilitate the reprogramming process. Ngn1 has a well-characterized role in nociceptor development and eventual TrpV1 expression 21 , but is involved much earlier in development (E9-13) than the other studied factors 20 . Thus, although developmental studies may inform the choice of transcription factors for lineage reprogramming, reprogramming studies may themselves provide insight into important developmental pathways and their regulators, recognizing of course that reprogramming may not recapitulate transcription factors expressed in normal development.
The intricacy and specificity of primary nociceptor neuron physiology and the fortunate ability to culture adult primary sensory neurons provide an unusual and well-controlled opportunity to evaluate how closely lineage-reprogrammed neurons resemble the molecular expression, function and maturity of primary adult neurons. We found that the reprogrammed neurons produced functional TrpV1, TrpA1 and TrpM8-expressing neurons in similar relative percentages to those found in primary tdTomato-positive adult mouse nociceptors. In addition, the induced neurons yielded not only functional TTX-resistant action potentials, but also the broad action potential morphology and phasic firing pattern characteristic of nociceptors. Indeed, their function globally was markedly close to that of adult primary nociceptors by every measure we made, although we cannot exclude other contributions, such as neuronal maturity, to firing pattern and action potential morphology. Future studies will need to explore the synaptic capacity, neurotrophin dependence and requirement for sustained viral transgene expression in the derived nociceptors.
Patient-derived neurons would have optimal utility as a drug screening tool if the derived neurons replicate the sequence of pathophysiological events that result in specific clinical diseases. Reprogrammed nociceptors may be particularly useful as an in vitro model for pain, as the pain-sensitization process mimicked by the induced nociceptors is one of the major factors that drive the transition to pathological pain. The development of a fluorescent nociceptorspecific marker will enable further optimization of human induced nociceptor maturation as well as more extensive molecular and physiological characterization of the human neurons. Whether nociceptors reprogrammed from individuals with chronic pain or peripheral neuropathy will reveal phenotypic differences compared with control subject-derived nociceptors can be evaluated in the future.
Analysis of FD patient tissue samples 40, 41 and FD induced pluripotent stem cell-derived neural precursors 42 have consistently shown the presence of both abnormally and normally spliced transcripts in the same sample. The detection of both splice forms could reflect either the presence of both normal and aberrant splicing in the affected neuronal types or simply the heterogeneity of affected and unaffected tissue types in the samples. Our finding that the normal IKBKAP splice variant was apparently absent in the FD-derived neurons indicates that the latter is likely the case, may have implications regarding the extent of splice correction necessary for disease treatment and may explain the observation in a mouse FD model that small amounts of IKAP are sufficient to revert the phenotype 46 . The reduction in outgrowth and branching in familial dysautonomia compared with control-derived neurons may reflect the presence of processes similar to those responsible for the progressive decrease in unmyelinated sensory neurons that is observed clinically 40 and the loss of TrkA-positive neurons in a mouse model 47 . The ability to obtain FD nociceptors from patient fibroblasts will allow future studies to examine the mechanisms of disease and to screen and evaluate potential treatments. Our results illustrate how derived neurons with major features of primary nociceptors can be generated and employed as a model for 'pain in a dish' .
Note Added in Proof: Blanchard et al. in this issue used a similar lineage reprogramming strategy and also obtained neurons with molecular and physiological properties that spanned different sensory neuron subtypes.
METhODS
Methods and any associated references are available in the online version of the paper. 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, 10 mM HEPES 10, pH 7.4. The probes were recorded after the application of capsaicin (1 µM concentration) or mustard oil (100 µM), which were applied at a 10× concentration at the edge of the well (far from the electrodes). Three replicates for each agonist, capsaicin and mustard oil, were completed from two separate transductions. For oxaliplatin sensitization experiments, cells were treated with either 50 µM oxaliplatin or vehicle control for 10 min and then recorded for one minute during treatment with 300 nM capsaicin.
Patch electrophysiology. Whole-cell patch recordings were performed on induced tdTomato-positive nociceptors, derived from Trpv1-Cre +/− ::tdTomato +/− MEFs, 4-5 weeks post-transduction and assessed for responses to capsaicin and α,β-methylene ATP (30 µM, Sigma), total and TTX-resistant (300 nM, Sigma) sodium currents, HCN depolarizating current sags and action potentials. Whole-cell current-clamp and voltage-clamp recordings were performed using a Multiclamp 700B (Molecular Devices) at 21-23 °C. Data were sampled at 20 kHz and digitized with a Digidata 1440A A/D interface and recorded using pCLAMP 10 software (Molecular Devices). Data were low-pass filtered at 2 kHz. Patch pipettes were pulled from borosilicate glass capillaries on a Sutter Instruments P-97 puller and had resistances of 2-4 MΩ. The pipette capacitance was reduced by wrapping the shank with Parafilm and compensated for using the amplifier circuitry. Series resistance was 5-10 MΩ and compensated by at least 80%.
For voltage-clamp recordings, voltages were elicited by 200-ms depolarizing steps from a holding potential of −80 mV to test potentials ranging from −100 mV to 30 mV in 10 mV increments. Responses to capsaicin (1 µM) and α,β-methylene ATP (30 µM) were measured in voltage clamp at a holding potential of −80 mV. Electrode drift was measured at the end of each recording and was typically 1-2 mV. The potassium-based intracellular solution contained 150 mM KCl, 2 mM MgCl 2 , 10 mM HEPES, 4 mM MgATP, 0.3 mM NaGTP, 10 mM Na 2 PhosCr, 1 mM EGTA, pH 7.4. For isolation of voltage-gated sodium currents, internal KCl was replaced by CsCl to block potassium currents and 100 µM CdCl 2 was applied to block calcium currents. 300 nM TTX was used to block TTX-sensitive voltage-gated sodium channels. HCN currents were measured by sequential hyperpolarizing steps in current clamp with an increment of −10-pA steps.
Quantification of cell number, axon length and axonal branching. All quantifications of cell count and morphological properties were performed by a researcher blind to genotype and condition. Reprogramming efficiency and percentage of TrpV1::tdTomato-positive, Tuj1-positive, peripherin-positive and CGRP-positive neurons were determined using MetaXpress software. The number of TrpV1:: tdTomato-positive (mouse, minimum of three wells from each of three separate transdifferentiations) and Tuj1-positive (human, minimum of 12 wells from each of three separate transdifferentiations) neurons was divided by the number of fibroblasts plated to calculate the reprogramming efficiency. Axon length and branching were quantified from the six age-matched human fibroblast lines (three HC and three FD) with images from eight wells (two transductions) and four wells (one transduction) of each line (20 wells total per line).
To quantify the number of TrpV1::tdTomato-positive neurons resulting from infection of different combinations of transcription factors, tdTomato-positive neurons were counted by hand in at least four separate wells for each condition from two separate transductions and averaged ( Fig. 1 and Supplementary  Fig. 4) . Given the variability of retroviral transductions with large numbers of viruses, we did not quantify experiments with transductions of 11-12 viruses at once (Supplementary Fig. 3 ). For comparison of five factors ± NeuroD1, images were taken of six wells of each condition from one transduction.
Statistical analyses. All tests are two-tailed using a significance threshold of 0.05. We used a Mann-Whitney U test to evaluate CGRP release after log transformation to equalize variance between groups (Fig. 4h) . This gave a W statistic of 16 (4 assays per group) and a P value of 0.03. We used a paired t test to evaluate baseline and PGE2-sensitized capsaicin responses in the induced mouse nociceptors (Fig. 5a ). This gave a T statistic of 4.61 with 20 degrees of freedom (21 cells) and a P value of 9.7 × 10 −4 . For comparison of transdifferentiation efficiency using five versus six factors, we used an unpaired t test to compare the average number of cells per field in six wells per group and got a T statistic of 6.1 with 10 degrees of freedom and P = 10 −4 (Supplementary Fig. 9) .
For morphological analyses of human HC-and FD-derived neurons, we performed analyses of cell number, axonal outgrowth and number of branches ( Fig. 6) . Distribution of cell number and number of branches were not normal (Shapiro-Wilk test). We looked at the distribution of all the measures graphically and found that they were approximately normal. Variance of cell number, axon outgrowth and number of branches were not different between HC-and FD-derived neurons (Levene test). Using random intercept model and taking matching of cell lines into account provided FD disease effect estimates (standard errors) compared with HC: A Supplementary methods checklist is available.
